Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Cardiff Oncology reports phase II results with onvansertib in mCRPC

Oct. 21, 2020

AstraZeneca discloses new PROTACs for cancer therapy

Oct. 21, 2020

PDAC subtypes point to targeting strategies

Oct. 21, 2020

New substudy evaluates Treadwell's CFI-400945 in metastatic CRPC

Oct. 20, 2020

Chinese researchers present new MAPK inhibitors

Oct. 20, 2020

Betta Pharmaceuticals patents EGFR mutant inhibitors

Oct. 20, 2020

Hinova Pharmaceuticals divulges new BRD4 and AR dual inhibitors

Oct. 20, 2020

Midatech presents phase I data for MTX-110 in diffuse intrinsic pontine glioma

Oct. 20, 2020

SWI/SNF mutations can lead to gain of function

Oct. 20, 2020

Aptose begins phase Ia/b study of CG-806 in AML

Oct. 19, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...